Dean Mula

Dean Mula

Dean has worked for more than 14 years in the life sciences industry. Previously, he led the Controllership functions at both AskBio [sold to Bayer AG in 2020] and Precision BioSciences [IPO in 2019].

Prior to that experience, Dean worked for several years in corporate finance at MedImmune, Cisco Systems, and HP. He began his career working as a CPA at Deloitte and holds degrees from Babson College and Bentley University.

Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2024 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science